Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.

× No keyword cloud information.

10 in total

Review 1. Update in cancer chemotherapy: genitourinary tract cancer, Part 5: Ovarian cancer.

Authors: J C Wright
Journal: J Natl Med Assoc Date: 1988-05 Impact factor: 1.798

2. Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy.

Authors: E Reed; S H Yuspa; L A Zwelling; R F Ozols; M C Poirier
Journal: J Clin Invest Date: 1986-02 Impact factor: 14.808

3. Prospective study with HEXA-CAF combination in ovarian carcinoma.

Authors: G De Palo; R Demicheli; P Valagussa; M De Lena; E Villa
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

4. Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Authors: D S Alberts; H S Chen; S E Salmon; E A Surwit; L Young; T E Moon; F L Meyskens
Journal: Cancer Chemother Pharmacol Date: 1981 Impact factor: 3.333

5. Preclinical evaluation of aclacinomycin A for the intraperitoneal treatment of human ovarian carcinoma.

Authors: K G Louie; T C Hamilton; B C Behrens; K R Grotzinger; W M McKoy; C E Myers; R C Young; R F Ozols
Journal: Cancer Chemother Pharmacol Date: 1986 Impact factor: 3.333

6. Hexamethylmelamine, adriamycin, and cyclophosphamide (HAC) versus cis-dichlorodiamineplatinum, adriamycin, and cyclophosphamide (PAC) in advanced ovarian cancer: a randomized clinical trial.

Authors: C Sessa; G Bolis; N Colombo; M D'Incalci; B Mermillod; I Valente; C Mangioni
Journal: Cancer Chemother Pharmacol Date: 1985 Impact factor: 3.333

Review 10. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy.

Authors: Elvira C van Dalen; Helena J H van der Pal; Leontien C M Kremer
Journal: Cochrane Database Syst Rev Date: 2016-03-03

10 in total

Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.